Kazuhiro Ikegame
About
Kazuhiro Ikegame is a scholar working on Hematology, Immunology and Oncology.
According to data from OpenAlex, Kazuhiro Ikegame has authored 154 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Hematology, 47 papers in Immunology and 40 papers in Oncology. Recurrent topics in Kazuhiro Ikegame's work include Hematopoietic Stem Cell Transplantation (100 papers), T-cell and B-cell Immunology (29 papers) and Acute Myeloid Leukemia Research (25 papers). Kazuhiro Ikegame is often cited by papers focused on Hematopoietic Stem Cell Transplantation (100 papers), T-cell and B-cell Immunology (29 papers) and Acute Myeloid Leukemia Research (25 papers). Kazuhiro Ikegame collaborates with scholars based in Japan, United States and Greece. Kazuhiro Ikegame's co-authors include Hiroyasu Ogawa, Katsuji Kaida, Satoshi Yoshihara, Hiroya Tamaki, Tatsuya Fujioka, Masaya Okada, Shinichiro Morishita, Manabu Kawakami, Kazuhisa Domen and Toshihiro Soma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Kazuhiro Ikegame
149 papers receiving 2.6k citations
Peers
Kazuhiro Ikegame
Arcangelo Prete Italy
Amin M. Alousi United States
Byung‐Sik Cho South Korea
Ron Ram Israel
Chang‐Ki Min South Korea
Derwood Pamphilon United Kingdom
Armin Gerbitz Canada
Hee‐Je Kim South Korea
Ki‐Seong Eom South Korea
Xiao‐Dong Mo China
Citations per year, relative to Kazuhiro Ikegame Kazuhiro Ikegame (= 1×)
peers
Arcangelo Prete
Countries citing papers authored by Kazuhiro Ikegame
Since
Specialization
Citations
This map shows the geographic impact of Kazuhiro Ikegame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Ikegame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Ikegame more than expected).
Fields of papers citing papers by Kazuhiro Ikegame
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kazuhiro Ikegame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Ikegame. The network helps show where Kazuhiro Ikegame may publish in the future.
Co-authorship network of co-authors of Kazuhiro Ikegame
This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Ikegame. A scholar is included among the top collaborators of Kazuhiro Ikegame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Ikegame. Kazuhiro Ikegame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fukunaga, Keiko, Kazuhiro Ikegame, Hirohisa Nakamae, et al.. (2024). HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis. International Journal of Hematology. 119(2). 173–182.
2.
Matsumoto, Kana, et al.. (2024). Individualized rabbit anti‐thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high‐risk hematologic malignancy: Exposure–response analysis and population pharmacokinetics simulations. American Journal of Hematology. 99(3). 387–395.
3.
Ito, Yuri, Yoshihiro Inamoto, Koichi Miyamura, et al.. (2023). Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades. Transplantation and Cellular Therapy. 29(12). 768.e1–768.e10.
4.
Jo, Tomoyasu, Yasuyuki Arai, Tadakazu Kondo, et al.. (2023). Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach. British Journal of Haematology. 202(2). 356–368.
5.
Yanagisawa, Ryu, Masaharu Tamaki, Reo Tanoshima, et al.. (2022). Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group. Hematological Oncology. 41(3). 535–545.
6.
Nishiwaki, Satoshi, Yu Akahoshi, Hiroaki Shimizu, et al.. (2022). Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades. Blood Advances. 6(15). 4558–4569.
7.
Inoue, Yoshitaka, Keiji Okinaka, Shigeo Fuji, et al.. (2021). Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplantation. 56(9). 2125–2136.
8.
Kobayashi, Shinichi, Yoshinobu Kanda, Takaaki Konuma, et al.. (2021). Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone Marrow Transplantation. 57(1). 43–50.
9.
Kurosawa, Shuhei, Shohei Mizuno, Yasuyuki Arai, et al.. (2021). Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. Blood Cancer Journal. 11(9). 159–159.
10.
Murata, Makoto, Seitaro Terakura, Atsushi Wake, et al.. (2021). Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplantation. 56(10). 2355–2366.
11.
Kaito, Satoshi, Yuho Najima, Kaito Harada, et al.. (2020). Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplantation. 55(7). 1337–1346.
12.
Kaito, Satoshi, Y. Nakajima, Konan Hara, et al.. (2020). Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Advances. 4(6). 1051–1061.
13.
Okamoto, Yasuhiro, Kazuko Kudo, Ken Tabuchi, et al.. (2019). Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia. Bone Marrow Transplantation. 54(9). 1489–1498.
14.
Arai, Yasuyuki, Tadakazu Kondo, Yasuhiko Shibasaki, et al.. (2019). Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood Advances. 3(22). 3626–3634.
15.
Morishita, Shinichiro, et al.. (2017). Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. European Journal of Cancer Care. 26(4). e12669–e12669.
16.
Morishita, Shinichiro, Katsuji Kaida, Osamu Aoki, et al.. (2015). Balance function in patients who had undergone allogeneic hematopoietic stem cell transplantation. Gait & Posture. 42(3). 406–408.
17.
Nishiwaki, Satoshi, Koichi Miyamura, Kazuteru Ohashi, et al.. (2013). Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Annals of Oncology. 24(6). 1594–1602.
18.
Tamaki, Hiroya, Tatsuya Fujioka, Kazuhiro Ikegame, et al.. (2012). Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation. European Journal Of Haematology. 89(6). 497–500.
19.
Taniguchi, K, Satoshi Yoshihara, Etsuko Maruya, et al.. (2012). Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors. Bone Marrow Transplantation. 47(10). 1338–1342.
20.
Shimizu, Jun, Jian‐Ping Zou, Kazuhiro Ikegame, Hiromi Fujiwara, & Toshiyuki Hamaoka. (1991). Antigen‐presenting Cells Constitutively Bind Tumor Antigens in the Tumor‐bearing State in vivo to Construct an Effective Immunogenic Unit. Japanese Journal of Cancer Research. 82(3). 262–265.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Arcangelo Prete Breakdown of academic impact, for papers by Amin M. Alousi Breakdown of academic impact, for papers by Byung‐Sik Cho Breakdown of academic impact, for papers by Ron Ram Breakdown of academic impact, for papers by Chang‐Ki Min Breakdown of academic impact, for papers by Derwood Pamphilon Breakdown of academic impact, for papers by Armin Gerbitz Breakdown of academic impact, for papers by Hee‐Je Kim Breakdown of academic impact, for papers by Ki‐Seong Eom Breakdown of academic impact, for papers by Xiao‐Dong Mo